Oxygenta Pharmaceutical (BOM:524636) 3-Year Revenue Growth Rate : -32.70% (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical 3-Year Revenue Growth Rate?

Oxygenta Pharmaceutical's Revenue per Share for the three months ended in Mar. 2024 was ₹3.20.

During the past 12 months, Oxygenta Pharmaceutical's average Revenue per Share Growth Rate was -43.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -32.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 20.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Oxygenta Pharmaceutical was 48.90% per year. The lowest was -32.70% per year. And the median was 23.10% per year.

Competitive Comparison of Oxygenta Pharmaceutical's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxygenta Pharmaceutical's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's 3-Year Revenue Growth Rate falls into.

Oxygenta Pharmaceutical 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Oxygenta Pharmaceutical (BOM:524636) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Oxygenta Pharmaceutical 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxygenta Pharmaceutical (BOM:524636) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032

Website

http://oxygentapharma.com

Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines